Request to Supply. If ITEOS requests supply of Licensed Product from GSK for Development activities (including Additional Development Activities) conducted hereunder, then prior to any such supply, the Parties will enter into a clinical supply agreement and quality agreement under which GSK will, subject to [Section 5.3] (Prioritization of Supply), supply Licensed Product to ITEOS at a supply price equal to ​. Any requests for supply of Licensed Product by ITEOS from GSK will be ordered under such clinical supply agreement pursuant to the terms thereof and the Parties will not be obligated to enter into any additional supply agreements. The clinical supply agreement shall include terms for the required lead time from the date GSK receives the purchase order from ITEOS and the requested delivery date in the purchase order and will be on terms customary for supply agreements between collaboration partners with respect to Development of products.

Supply of Other Products by GSK. If the Global Development Plan includes Clinical Trials to be conducted by ITEOS for the Development of a ​, then # GSK will be responsible for supplying such ​, for use under the Global Development Plan and # the Parties will enter into a clinical supply agreement and a quality agreement (or add such ​ to the supply agreement previously entered into by the Parties pursuant to [Section 5.1.4] (Request to Supply)), as necessary for GSK to ​ to ITEOS for the purpose of conducting the applicable Clinical Trials in accordance with the Global Development Plan. ​.